Skip to main content
Cureus logoLink to Cureus
. 2023 Jun 14;15(6):e40412. doi: 10.7759/cureus.40412

Continuous Epidural Analgesia Versus Continuous Peripheral Nerve Block in Unilateral Lower Extremity Pediatric Orthopedic Surgery: A Matched Case Comparison Study

Neeraj Vij 1, Neil R Singhal 2, Daniel Trif 3, Aaron Llanes 1, Ali Fanharawi 2, Matt Pankratz 2, Sanjana Khanna 2, Mohan Belthur 4,5,
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10348071  PMID: 37456471

Abstract

Introduction

Continuous epidural analgesia (CEA) provides effective postoperative pain relief but includes a substantial side effect profile. Continuous peripheral nerve blocks (CPNBs) have fewer side effects and may quicken ambulation. The purpose of this study was to compare the morphine milligram equivalents (MMEs), need for analgesic rescue, visual analog scale (VAS) pain scores, time to ambulation, postoperative blood pressures, length of stay (LOS), and adverse event rates.

Methods

This was a matched case comparison study of pediatric patients (ages 8-17) undergoing unilateral lower limb surgery (41 CEA and 36 CPNB). Patients with a history of chronic pain, previous lower extremity surgery, and developmental delay were excluded. The Chi-square test and Student’s t-test were used, and p-values < 0.05 were considered significant.

Results

There were no statistically significant differences in demographics or the American Society of Anesthesiologists (ASA) grade. There were no significant differences in postoperative MMEs, the need for analgesic rescue, or VAS scores on any postoperative day. The CEA group had a longer time to ambulation (2.56 ± 0.93 days versus 1.89 ± 0.69 days, p = 0.004). The CEA group demonstrated a higher number of days of systolic hypotension (0.61 ± 0.97 mmHg versus 0.06 ± 0.23 mmHg, p = 0.0009) and diastolic hypotension (1.90 ± 1.24 mmHg versus 1.00 ± 0.93 mmHg, p = 0.0006). There were no significant differences in the length of stay between the CEA and CPNB groups (5.08 versus 4.24, p = 0.28). There was no statistically significant difference between the rates of pruritus, light-headedness, and altered mental status. The CEA group demonstrated higher rates of nausea (51.2% versus 13.9%, p = 0.001), constipation (36.6% versus 8.3%, p = 0.004), urinary retention (9.8% versus 0%, p = 0.006), and average number of minor adverse events per patient (1.02 versus 0.25, p = 0.002).

Conclusions

CPNBs and CEAs demonstrate equivalent postoperative opioid use after unilateral lower extremity surgery in the pediatric population. In our population, a low complication rate and a decreased time to ambulation were seen in the CPNB group. There may be certain select scenarios priorly managed with a CEA that can be appropriately managed with a CPNB. A prospective multicenter study incorporating patient satisfaction data could further facilitate the incorporation of CPNB in pediatric pain management protocols after orthopedic surgery.

Keywords: postoperative pain control, pediatric regional anesthesia, continuous epidural analgesia, pediatric lower extremity surgery, continuous peripheral nerve block

Introduction

Practices regarding pediatric anesthesia have changed in recent years [1]. Several advances have affected the current practice surrounding regional anesthesia [2]. This includes advances in ultrasound guidance [3,4], nerve mapping [5], and anesthetic choice. These have facilitated the incorporation of single-shot and continuous peripheral nerve blocks (CPNBs) for pain relief after pediatric surgery. The increase in the use of CPNBs within pediatric anesthesia has correlated with a decrease in neuraxial anesthesia [2].

Alternative options for postoperative pain control after pediatric orthopedic surgery include a single-shot regional nerve block, single-shot caudal analgesia, or continuous epidural analgesia (CEA). However, epidural analgesia comes with a significant side effect profile including nausea, vomiting, and urinary retention. There is also a high complication rate after epidural analgesia, including cardiac morbidity, pulmonary embolism, and acute renal failure [6]. Side effects are noticeably higher in the pediatric population [7]. A recent study reported an incidence of 7.6 in 1,000 for a major complication (life-threatening injury or significant neurologic deficit), which is more than 10 times higher than the major complication rate in adults [8].

CPNBs are effective in providing adequate pain-free days and decreasing reliance on opioids in the postoperative period [9-12]. There has been much excitement regarding the increased utilization of CPNBs after pediatric orthopedic surgery, although clinical efficacy studies are lacking [13,14].

It is well known that perineural analgesia is a safe modality for pain control in the pediatric population [3,9,15,16]. An analysis of 100,000 blocks from the Pediatric Regional Anesthesia Network (PRAN) demonstrated a very low complication rate with no sequelae lasting greater than three months [16]. CPNBs have also demonstrated good patient satisfaction scores in the pediatric population [17]. However, there are limited reports regarding the clinical efficacy of the CPNB in terms of pain scores and postoperative opioid requirements [12].

As the literature around CPNB grows, surgical teams have become more comfortable using CPNB as the mainstay of postoperative pain control [13,14,18]. There are many clinical scenarios in which CPNB would not provide adequate postoperative analgesia and thus may warrant a form of neuraxial anesthesia. However, as the evidence behind CPNB increases, there may be clinical scenarios priorly controlled with a CEA that may be amenable to CPNB as a promising alternative. The purpose of this study is to compare CPNB to CEA after lower extremity pediatric orthopedic surgery. The primary outcome of this study was the postoperative morphine milligram equivalents (MMEs). The secondary outcomes were the need for analgesic rescue, VAS pain scores, time to ambulation, postoperative blood pressures, length of stay (LOS), and adverse event rates. We hypothesized that there would be no difference in MMEs, need for analgesic rescue, VAS pain scores, or LOS between the groups and that the CPNB group would have a shorter time to ambulation, decreased rates of postoperative hypotension, and decreased adverse event rates.

Materials and methods

General

This was a retrospective, matched case comparison study at a large tertiary referral center that was approved by our Institutional Review Board (IRB number 16-053). The patient charts for all patients receiving lower extremity orthopedic surgery in consultation with the pain service were searched and divided into the following categories: single-shot epidural, continuous epidural; single-shot nerve block; and continuous nerve block. Pediatric patients (ages 0-18) who received unilateral lower extremity orthopedic surgery were included. Patients from the single-shot groups, patients undergoing bilateral lower extremity surgery, and patients with a history of chronic pain, previous lower extremity surgery, and developmental delay were excluded. The CPNBs used in our study included lumbar plexus (4), femoral (8), popliteal (17), and femoral + popliteal (7). The patients included in the continuous peripheral nerve block (CPNB) group were age- and gender-matched to the patients in the continuous epidural analgesia (CEA) group.

Data collection and management

Data was collected using Microsoft Excel version 16.66.61 (Microsoft Corp., Redmond, WA, USA) and stored in an encrypted folder on our institution’s secure network between October 1, 2014, and December 31, 2021. The demographic variables obtained included gender, age, height, and weight. Surgical information obtained included the date, details of the surgery, and ASA grade. Postoperative pain information collected included the choice of continuous analgesic modality, continuous medication given, length of use, daily morphine usage, other opioid medications given, any non-opioid medications given, and length of stay (LOS). The need for analgesic rescue (defined as a requirement for any as-needed analgesic medication) was also recorded [19]. All minor adverse events [13] (infection, pruritus, nausea/vomiting, urinary retention, constipation, overdose, or compartment syndrome) and major adverse events [13] (permanent neurologic injury or mortality) were gathered. Systolic and diastolic blood pressures immediately postoperatively and on postoperative day 1 were recorded. The number of days of systolic/diastolic hypotension was also recorded. MMEs were calculated using the daily pro re nata (PRN) and patient-controlled analgesia (PCA) [20]. The visual analog scale (VAS), which has demonstrated excellent validity in the age ranges 8-18 [13,21], was used to collect pain scores within the 0-12 hour, 12-24 hour, 24-36 hour, and 36-48 hour postoperative periods. The postoperative days of rehabilitation initiation and ambulation were also recorded.

Data abstraction and statistical analysis

Continuous variables were reported as means and standard deviations (SDs) and categorical variables as frequencies and proportions. A preliminary power analysis was performed, and it was determined that to detect a mean difference of MMEs that is equal to its standard deviation, 35 patients would need to be recruited to each group to achieve a statistical power of greater than 90%. The Chi-square test was used to compare continuous variables. Student’s t-test was used to compare categorical variables. SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses. P-values were two-tailed, and statistical significance was set at p < 0.05.

Results

General

There were a total of 35 males and 42 females in our study with an average age of 11.32 (± 2.80) years. There were no statistically significant differences in gender, age, body mass index (BMI), or ASA grades between the two groups (Table 1).

Table 1. Our population demographics and the ASA grade for our study groups.

ASA: American Society of Anesthesiologists, CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block

Variable CEA group (n = 41) CPNB group (n = 36) P-value
Males 18, 43.9% 17, 47.2% 0.77
Age 11.02 ± 2.80 11.67 ± 2.81 0.32
Body mass index 23.68 ± 8.47 24.35 ± 13.19 0.8
ASA grade 1 22 (53.7) 14 (38.9) 0.41
ASA grade 2 13 (31.7) 16 (44.4)
ASA grade 3 6 (14.6) 6 (16.7)

The surgeries performed in the CPNB and CEA groups can be seen in Figure 1.

Figure 1. Surgeries received by the CPNB and CEA groups.

Figure 1

The “Other” group consisted of two patients who received excision and curettage of a femoral lesion and one patient who received a hamstring lengthening procedure (CEA group) and one patient who received a subtalar arthrodesis (CPNB group).

One CPNB and two CEA patients from the femoral osteotomy groups concurrently received a distal femoral hemiepiphysiodesis for the treatment of miserable malalignment.

CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block

Opioid use and analgesic rescue

There were no significant differences in MMEs required on any postoperative day (measured up to postoperative day 3) between the two groups (Table 2).

Table 2. Total postoperative morphine milligram equivalent requirements (mg/kg).

CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block

Postoperative day CEA group (n = 41) CPNB group (n = 36) P-value
0 0.116 ± 0.206 0.065 ± 0.021 0.19
1 0.179 ± 0.188 0.129 ± 0.113 0.15
2 0.115 ± 0.017 0.112 ± 0.019 0.92
3 0.076 ± 0.086 0.066 ± 0.101 0.65

There were no significant differences in the need for analgesic rescue at any point in the hospital stay between the CEA and CPNB groups (80.4% versus 86.1%, p = 0.88).

VAS pain scores

There were no statistically significant differences in pain scores between the CEA and CPNB groups in any postoperative period (Table 3).

Table 3. VAS pain scores after surgery.

VAS: visual analog scale, CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block

Postoperative period (hours) CEA group (n = 41) CPNB group (n = 36) P-value
0-12 1.16 ± 1.69 1.14 ± 1.95 0.98
12-24 2.11 ± 1.78 1.46 ± 1.33 0.08
24-36 1.85 ± 1.75 1.61 ± 1.45 0.52
36-48 1.69 ± 1.54 1.28 ± 1.41 0.23

Rehabilitation and ambulation

The CEA group had a longer time to rehabilitation initiation (1.89 ± 0.86 days versus 1.15 ± 0.78 days, p = 0.0003) and a longer time to ambulation (2.56 ± 0.93 days versus 1.89 ± 0.69 days, p = 0.004) than the CPNB group (Table 4).

Table 4. Comparison of rehabilitation initiation and ambulation between our groups.

Two patients in both groups denied therapy. Fourteen (34.2%) patients and eight (22.2%) patients from the CEA and CPNB groups did not ambulate during their hospital stay.

CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block, SD: standard deviation

  Postoperative day CEA group (n = 41) CPNB group (n = 36) P-value
Rehabilitation initiation 0 2 (5%) 4 (11.1%) 0.0002
1 10 (25%) 24 (66.7%)
2 16 (40%) 4 (11.1%)
3 10 (25%) 1 (2.8%)
4 0 1 (2.8%)
Overall (average, SD) 1.89 ± 0.86 1.15 ± 0.78 0.0003
Day of ambulation 0 1 (2.4%) 0 0.006
1 1 (2.4%) 7 (19.4%)
2 10 (24.4%) 18 (50%)
3 13 (31.7%) 2 (5.6%)
4 1 (2.4%) 1 (2.8%)
5 1 (2.4%) 0
Overall (average, SD) 2.56 ± 0.93 1.89 ± 0.69 0.004

A total of eight patients in the CPNB group did not ambulate during their hospital stay. This included four distal femoral osteotomy patients, two foot reconstruction with osteotomy patients, and two soft tissue foot reconstruction patients. A total of 14 patients in the CEA group did not ambulate during their hospital stay. This included one proximal femoral osteotomy patient, 12 distal femoral osteotomy patients, and one patient who received an excision and curettage of a femoral lesion.

Blood pressure

The CEA group demonstrated a higher number of days of systolic hypotension (0.61 ± 0.97 mmHg versus 0.06 ± 0.23 mmHg, p = 0.0009) and diastolic hypotension (1.90 ± 1.24 mmHg versus 1.00 ± 0.93 mmHg, p = 0.0006) than the CPNB group (Table 5).

Table 5. Comparison of blood pressure data between our groups.

Systolic hypotension was defined as <120 mmHg, and diastolic hypotension was defined as <90 mmHg [16].

CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block

  Postoperative day CEA group (n = 41) CPNB group (n = 36) P-value
Systolic hypotension 0 27 (65.9%) 34 (94.4%) 0.01
1 6 (14.6%) 2 (5.6%)
2 5 (12.2%) 0
3 3 (7.3%) 0
Overall (days) 0.61 ± 0.97 0.06 ± 0.23 0.0009
Diastolic hypotension 0 5 (12.2%) 13 (36.1%) 0.04
1 12 (29.3%) 12 (33.3%)
2 11 (26.8%) 9 (25%)
3 9 (22%) 2 (2.6%)
4 3 (7.3%) 0
5 1 (2.4%) 0
Overall (days) 1.90 ± 1.24 1.00 ± 0.93 0.0006

Length of stay

There were no significant differences in the length of stay between the CEA group and the CPNB group (5.08 versus 4.24, p = 0.28) (Table 6).

Table 6. Comparison of length of stay between the two groups.

CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block, SD: standard deviation

Length of stay (days) CEA group (n = 41) CPNB group (n = 36) P-value Overall (N = 77)
<3 2 (4.9) 3 (8.3) 0.2 5 (6.5)
3-4 24 (58.5) 21 (58.3) 45 (58.4)
5-9 15 (36.6) 9 (25) 24 (31.2)
>10 0 3 (8.3) 3 (3.9)
Overall (average, SD) 5.08 ± 4.4 4.24 ± 1.30 0.28 4.64 ± 3.21

Adverse events

There were no major adverse events in either group. There was no statistically significant difference between the rates of pruritus, light-headedness, and altered mental status between the CEA and CPNB groups (Table 7).

Table 7. Comparison of adverse events between the two groups.

CEA: continuous epidural analgesia, CPNB: continuous peripheral nerve block

Minor adverse event CEA group (n = 41) CPNB group (n = 36) P-value Overall (N = 77)
Pruritus 2 (4.9%) 1 (2.8%) 0.63 3 (3.9%)
Nausea 20 (51.2%) 5 (13.9%) 0.001 25 (32.5%)
Constipation 15 (36.6%) 3 (8.3%) 0.004 18 (23.4%)
Urinary retention 4 (9.8%) 0 0.006 4 (5.2%)
Light-headedness 1 (2.4%) 0 0.35 1 (1.3%)
Altered mental status 1 (2.4%) 0 0.35 1 (1.3%)
Average number of minor adverse events per patient 1.02 0.25 0.0002 0.66

The CEA group demonstrated higher rates of nausea (51.2% versus 13.9%, p = 0.001), constipation (36.6% versus 8.3%, p = 0.004), urinary retention (9.8% versus 0%, p = 0.006), and average number of minor adverse events per patient (1.02 versus 0.25, p = 0.002).

Discussion

This matched case comparison study identified 41 and 36 patients in whom CEA and CPNB were the primary forms of postoperative analgesia, respectively. Both groups encompassed a similar spectrum of lower extremity orthopedic surgeries. We demonstrated no difference in postoperative MMEs, need for analgesic rescue, VAS scores, or LOS. The CPNB group demonstrated a shorter time to ambulation, decreased postoperative hypotension, and a decreased minor adverse event rate.

It is important to consider postoperative opioid use when considering the choice of regional anesthesia in children undergoing orthopedic surgery [22,23]. There has been much conversation regarding the reduction of opioid use after pediatric orthopedic surgery [24,25]. Opioids are often overprescribed [14] and underutilized [25] after pediatric orthopedic surgery. Further, the harsh side effects of opioids are seen in higher numbers in children [3]. However, postoperative pain management protocols in orthopedics generally do not take into account the variety of multimodal options available to patients, and perineural techniques remain underused [26]. The results of our study favor more frequent utilization of CPNBs in children undergoing unilateral lower extremity orthopedic surgery. There are certain scenarios in which a CPNB may be insufficient, and ultimately, the decision about using a CEA or alternative regional anesthesia should be made based on the involvement of both extremities, intensiveness of the procedure, surgical site, and family/patient preferences.

There is good data to suggest a low adverse event rate with the use of continuous peripheral nerve blocks. The published literature demonstrates a minor adverse event rate of 17% and a nausea/vomiting rate of 14.7% [12,13]. This correlated well with our minor adverse event rate of 25% and nausea/vomiting rate of 13.9%. This is in contrast to the nausea/vomiting rate of 51.2% seen in our CEA population, which also coincides with the literature [8]. The safety and practice patterns analysis from the PRAN demonstrated a minor adverse event rate of 12.1% [27], although notably, their large-scale study did include other side effects including persistent neurologic problems, infection, and local anesthetic systemic toxicity (LAST) that were also not seen in our review of 77 patients. CPNBs are not without their limitations, including inadequate pain relief in the proximal extremities, limitations to patients undergoing unilateral surgery, and reliance on a pain team. Nevertheless, in the appropriate clinical scenario, the low adverse event rate seen in our study does demonstrate some favorability.

A recently published article highlights the aforementioned points. Laron et al. [22] demonstrated that in patients with cerebral palsy undergoing hip reconstructive surgery, the fascia iliaca block provides decreased postoperative pain scores and decreased opioid usage than continuous lumbar epidural analgesia. These encouraging results are in line with the findings of our study. An interesting consideration is whether more of the femoral osteotomy patients in our study could be managed more appropriately with a fascia iliaca block. In our study, the two proximal femoral osteotomy patients received a CEA. Nonetheless, the results of Laron et al. [22] are encouraging, and further studies should aim to determine the efficacy of peripheral analgesic options in hip surgery in children.

In the published literature, local analgesia proves to be as successful or even better than epidural analgesia in select scenarios. Novais et al. [23] demonstrated equivalent postoperative pain scores and opioid consumption in patients who received periarticular local infiltrative analgesia as compared to those who received epidural analgesia in the context of surgical hip dislocation for the treatment of femoroacetabular impingement. While the results of this study are specific to a select patient population and thus the clinical scenarios warranting epidural analgesia remain plentiful, this study further highlights the role of local and regional analgesic options in pediatric patients undergoing orthopedic surgery.

There have been several recent advances within regional anesthesia that further make CPNB an attractive option in the right clinical scenario. This includes nerve mapping and advances in ultrasound techniques that allow for better visualization in children [4]. Perineural catheters can be placed with increasing ease in children [28], which further makes CPNBs an attractive option. At our institution, nerve blocks are placed by board-certified pediatric anesthesiologists under direct sonographic visualization without nerve mapping. In our study, this yielded a low complication rate similar to that seen in the published literature [13,27].

It is well known that early mobilization leads to improved functional outcomes after orthopedic surgery [29,30]. Early mobilization leads to decreased complications in children undergoing pediatric orthopedic surgery [30]. In our study, the majority (66.7%) of the CPNB group began rehabilitation on the first postoperative day and were ambulatory (50%) by the second postoperative day. It is important to keep in mind that the patient’s perceived mental strength and the physical therapist’s perception of the patient’s health may have influenced the earlier time to ambulation seen in the CPNB group. Our ability to draw conclusions on this result is very limited due to the heterogeneity of operations and their effect on ambulatory status. The association between CPNB and early mobilization should be explored in future studies.

Limitations

This was a non-randomized, retrospective study and is thus subject to inherent limitations. Although our study groups were age- and gender-matched and did demonstrate similarity in ASA grades, there is an element of heterogeneity in terms of procedures performed. Our study took place at a single tertiary referral pediatric hospital with a highly trained pain service, and thus, our results may not be generalizable. Certain pain practitioners may have a bias toward one nerve block over another. Lastly, our sample size of 77 patients was chosen to power our study with regard to MMEs; thus, there is a risk of type II statistical error concerning the secondary outcomes.

Conclusions

CPNBs and CEAs demonstrate equivalent postoperative opioid use after unilateral lower extremity surgery in the pediatric population. In our population, a low complication rate and a decreased time to ambulation were seen in the CPNB group. There may be certain select scenarios priorly managed with a CEA that can be appropriately managed with a CPNB. A prospective multicenter study incorporating patient satisfaction data could further facilitate the incorporation of CPNB in pediatric pain management protocols after orthopedic surgery.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Fundamentals and innovations in regional anaesthesia for infants and children. Heydinger G, Tobias J, Veneziano G. Anaesthesia. 2021;76 Suppl 1:74–88. doi: 10.1111/anae.15283. [DOI] [PubMed] [Google Scholar]
  • 2.A review of pediatric regional anesthesia practice during a 17-year period in a single institution. Rochette A, Dadure C, Raux O, Troncin R, Mailheé P, Capdevila X. Paediatr Anaesth. 2007;17:874–880. doi: 10.1111/j.1460-9592.2007.02217.x. [DOI] [PubMed] [Google Scholar]
  • 3.Continuous central and perineural infusions for postoperative pain control in children. Ivani G, Mossetti V. Curr Opin Anaesthesiol. 2010;23:637–642. doi: 10.1097/ACO.0b013e32833d4f81. [DOI] [PubMed] [Google Scholar]
  • 4.Long-axis ultrasound imaging of the nerves and advancement of perineural catheters under direct vision: a preliminary report of four cases. Koscielniak-Nielsen ZJ, Rasmussen H, Hesselbjerg L. https://pubmed.ncbi.nlm.nih.gov/18774519/ Reg Anesth Pain Med. 2008;33:477–482. doi: 10.1016/j.rapm.2008.02.009. [DOI] [PubMed] [Google Scholar]
  • 5.Pediatric ambulatory continuous peripheral nerve blocks. Antony S, Gurnaney H, Ganesh A. Anesthesiol Clin. 2018;36:455–465. doi: 10.1016/j.anclin.2018.05.003. [DOI] [PubMed] [Google Scholar]
  • 6.The role of epidural anesthesia and analgesia in surgical practice. Moraca RJ, Sheldon DG, Thirlby RC. Ann Surg. 2003;238:663–673. doi: 10.1097/01.sla.0000094300.36689.ad. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.The national pediatric epidural audit. Llewellyn N, Moriarty A. Paediatr Anaesth. 2007;17:520–533. doi: 10.1111/j.1460-9592.2007.02230.x. [DOI] [PubMed] [Google Scholar]
  • 8.Major complications related to epidural analgesia in children: a 15-year audit of 3,152 epidurals. Wong GK, Arab AA, Chew SC, Naser B, Crawford MW. Can J Anaesth. 2013;60:355–363. doi: 10.1007/s12630-012-9877-3. [DOI] [PubMed] [Google Scholar]
  • 9.Does the performance of lower limb peripheral nerve blocks differ among orthopedic sub-specialties? A single institution experience in 246 patients. Ghaffari A, Jørgensen MK, Rømer H, Sørensen MP, Kold S, Rahbek O, Bisgaard J. Scand J Pain. 2021;21:794–803. doi: 10.1515/sjpain-2021-0029. [DOI] [PubMed] [Google Scholar]
  • 10.Postoperative analgesia for elective total knee arthroplasty under subarachnoid anesthesia with opioids: comparison between epidural, femoral block and adductor canal block techniques (with and without perineural adjuvants). A prospective, randomized, clinical trial. Ortiz-Gómez JR, Perepérez-Candel M, Vázquez-Torres JM, Rodriguez-Del Río JM, Torrón-Abad B, Fornet-Ruiz I, Palacio-Abizanda FJ. Minerva Anestesiol. 2017;83:50–58. doi: 10.23736/S0375-9393.16.11646-3. [DOI] [PubMed] [Google Scholar]
  • 11.Extended-release epidural morphine vs continuous peripheral nerve block for management of postoperative pain after orthopedic knee surgery: a retrospective study. Schmidt NR, Donofrio JA, England DA, McDonald LB, Motyka CL, Mileto LA. https://pubmed.ncbi.nlm.nih.gov/19911644/ AANA J. 2009;77:349–354. [PubMed] [Google Scholar]
  • 12.Ambulatory continuous peripheral nerve blocks in children and adolescents: a longitudinal 8-year single center study. Gurnaney H, Kraemer FW, Maxwell L, Muhly WT, Schleelein L, Ganesh A. Anesth Analg. 2014;118:621–627. doi: 10.1213/ANE.0b013e3182a08fd4. [DOI] [PubMed] [Google Scholar]
  • 13.Continuous peripheral nerve blocks for postoperative analgesia in children: feasibility and side effects in a cohort study of 339 catheters. Dadure C, Bringuier S, Raux O, et al. Can J Anaesth. 2009;56:843–850. doi: 10.1007/s12630-009-9169-8. [DOI] [PubMed] [Google Scholar]
  • 14.Does a continuous peripheral nerve block reduce home opioid use in children and adolescents following anterior cruciate ligament reconstruction? The envelope please. Schlechter JA, Harrah T, Gornick B, Sherman B. Orthop J Sports Med. 2021;9:2325967121. doi: 10.1097/BPO.0000000000002082. [DOI] [PubMed] [Google Scholar]
  • 15.The safety and efficacy of the continuous peripheral nerve block in postoperative analgesia of pediatric patients. Simić D, Stević M, Stanković Z, Simić I, Dučić S, Petrov I, Milenović M. https://pubmed.ncbi.nlm.nih.gov/29594120/ Front Med (Lausanne) 2018;5:57. doi: 10.3389/fmed.2018.00057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Complications in pediatric regional anesthesia: an analysis of more than 100,000 blocks from the Pediatric Regional Anesthesia Network. Walker BJ, Long JB, Sathyamoorthy M, et al. Anesthesiology. 2018;129:721–732. doi: 10.1097/ALN.0000000000002372. [DOI] [PubMed] [Google Scholar]
  • 17.The effectiveness of ambulatory continuous peripheral nerve blocks for postoperative pain management in children and adolescents. Visoiu M, Joy LN, Grudziak JS, Chelly JE. Paediatr Anaesth. 2014;24:1141–1148. doi: 10.1111/pan.12518. [DOI] [PubMed] [Google Scholar]
  • 18.Pediatric Regional Anesthesia Network (PRAN): a multi-institutional study of the use and incidence of complications of pediatric regional anesthesia. Polaner DM, Taenzer AH, Walker BJ, et al. Anesth Analg. 2012;115:1353–1364. doi: 10.1213/ANE.0b013e31825d9f4b. [DOI] [PubMed] [Google Scholar]
  • 19.Oral oxycodone for acute postoperative pain: a review of clinical trials. Cheung CW, Wong SSC, Qiu Q, Wang X. https://pubmed.ncbi.nlm.nih.gov/28226340/ Pain Physician. 2017;20:0. [PubMed] [Google Scholar]
  • 20.Centers for Disease Control and Prevention: Calculating total daily dose of opioids for safer dosage. [ Dec; 2022 ]. 2017. https://www.cdc.gov/opioids/providers/prescribing/pdf/calculating-total-daily-dose.pdf https://www.cdc.gov/opioids/providers/prescribing/pdf/calculating-total-daily-dose.pdf
  • 21.Validation of the Wong-Baker FACES Pain Rating Scale in pediatric emergency department patients. Garra G, Singer AJ, Taira BR, Chohan J, Cardoz H, Chisena E, Thode HC Jr. Acad Emerg Med. 2010;17:50–54. doi: 10.1111/j.1553-2712.2009.00620.x. [DOI] [PubMed] [Google Scholar]
  • 22.Fascia iliaca pain block results in lower overall opioid usage and shorter hospital stays than epidural anesthesia after hip reconstruction in children with cerebral palsy. Laron D, Kelley J, Chidambaran V, McCarthy J. J Pediatr Orthop. 2022;42:96–99. doi: 10.1097/BPO.0000000000002028. [DOI] [PubMed] [Google Scholar]
  • 23.Local Infiltration analgesia compared with epidural and intravenous PCA after surgical hip dislocation for the treatment of femoroacetabular impingement in adolescents. Novais EN, Kestel L, Carry PM, Sink E, Strupp K. J Pediatr Orthop. 2018;38:9–15. doi: 10.1097/BPO.0000000000000725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Refilling opioid prescriptions after pediatric orthopaedic surgery: an analysis of incidence and risk factors. Meza BC, Swarup I, Woodard T, Cazzulino A, Talwar D, Shah AS. J Pediatr Orthop. 2021;41:0–5. doi: 10.1097/BPO.0000000000001736. [DOI] [PubMed] [Google Scholar]
  • 25.Opioid prescriptions after pediatric orthopedic surgery: analyzing rates of unfilled prescriptions. Cazzulino A, Meza BC, Woodard T, Swarup I, Shah AS. J Pediatr Orthop. 2021;41:457–462. doi: 10.1097/BPO.0000000000001859. [DOI] [PubMed] [Google Scholar]
  • 26.Current issues in postoperative pain management. Rawal N. Eur J Anaesthesiol. 2016;33:160–171. doi: 10.1097/EJA.0000000000000366. [DOI] [PubMed] [Google Scholar]
  • 27.Peripheral nerve catheters in children: an analysis of safety and practice patterns from the pediatric regional anesthesia network (PRAN) Walker BJ, Long JB, De Oliveira GS, Szmuk P, Setiawan C, Polaner DM, Suresh S. Br J Anaesth. 2015;115:457–462. doi: 10.1093/bja/aev220. [DOI] [PubMed] [Google Scholar]
  • 28.Pediatric regional anesthesia: a review of the relevance of surface anatomy and landmarks used for peripheral nerve blockades in infants and children. Byun S, Pather N. Clin Anat. 2019;32:803–823. doi: 10.1002/ca.23406. [DOI] [PubMed] [Google Scholar]
  • 29.Orthopaedic surgery in the elderly. Borgeat A, Ekatodramis G. Best Pract Res Clin Anaesthesiol. 2003;17:235–244. doi: 10.1016/s1521-6896(03)00007-7. [DOI] [PubMed] [Google Scholar]
  • 30.Principles of surgical management of musculoskeletal conditions. Venkatesh R. Best Pract Res Clin Rheumatol. 2008;22:483–498. doi: 10.1016/j.berh.2008.02.005. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES